1. Home
  2. CPSH vs NSRX Comparison

CPSH vs NSRX Comparison

Compare CPSH & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CPS Technologies Corp.

CPSH

CPS Technologies Corp.

HOLD

Current Price

$5.37

Market Cap

67.6M

ML Signal

HOLD

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$7.05

Market Cap

63.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CPSH
NSRX
Founded
1984
2019
Country
United States
Israel
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.6M
63.4M
IPO Year
1987
2025

Fundamental Metrics

Financial Performance
Metric
CPSH
NSRX
Price
$5.37
$7.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$6.00
$20.50
AVG Volume (30 Days)
215.9K
9.2K
Earning Date
10-29-2025
02-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$30,321,555.00
N/A
Revenue This Year
$55.87
N/A
Revenue Next Year
$19.98
N/A
P/E Ratio
N/A
N/A
Revenue Growth
38.22
N/A
52 Week Low
$1.40
$5.90
52 Week High
$5.23
$9.99

Technical Indicators

Market Signals
Indicator
CPSH
NSRX
Relative Strength Index (RSI) 81.46 N/A
Support Level $4.30 N/A
Resistance Level $4.94 N/A
Average True Range (ATR) 0.37 0.00
MACD 0.22 0.00
Stochastic Oscillator 96.52 0.00

Price Performance

Historical Comparison
CPSH
NSRX

About CPSH CPS Technologies Corp.

CPS Technologies Corp provides material solutions to the transportation, automotive, energy, computing/Internet, telecommunications, aerospace, defense, and oil and gas end markets. Its primary material solution is metal matrix composites (MMCs), which are a class of materials consisting of a combination of metal and ceramic. The company designs, manufactures and sells custom MMC components, which manages the performance and reliability of systems in the end markets. It also provides baseplates and housings used in radar, satellite and avionics applications. The company provides lids and heat spreaders used with integrated circuits in Internet switches and routers.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: